Company
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals has 6 drugs tracked on RxWires: 1 post-market, 2 in Phase 3, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Rezdiffra | Post-Market | MASH - Metabolic Dysfunction-Associated Steatohepatitis |
| Resmetirom | Phase 3 | Non-Alcoholic Fatty Liver Disease |
| MGL-3196 | Phase 3 | NASH - Nonalcoholic Steatohepatitis |
| Atorvastatin | Phase 1 | Healthy |
| VIA-3196 | Phase 1 | Drug Safety |
| Simvastatin | Phase 1 | Healthy |
Latest
- madrigal pharmaceuticals filed 8-K
- madrigal pharmaceuticals filed 8-K
- madrigal pharmaceuticals filed 8-K
- madrigal pharmaceuticals filed 8-K
- madrigal pharmaceuticals filed 8-K
Follow Madrigal Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.